DRMA

Dermata Therapeutics Inc

• TipRanks·05/27 22:09

  Dermata Therapeutics Shareholders Approve Equity Plan and Directors

• TipRanks·05/19 19:45

  Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4

• Seeking Alpha·05/13 20:59

  Dermata Therapeutics GAAP EPS of -$0.48 beats by $0.05

• TipRanks·04/02 12:39

  Dermata receives notice of acceptance of Australian patent application

• TipRanks·04/01 12:35

  Dermata Therapeutics price target lowered to $4 from $10 at Maxim

• Seeking Alpha·03/27 14:16

  Dermata Therapeutics GAAP EPS of -$8.16

• TipRanks·03/05 14:07

  Dermata Therapeutics announces release of Tome Skincare

• TipRanks·02/25 21:59

  Dermata Therapeutics Announces Board Resignation and Size Reduction

• TipRanks·01/27 14:29

  Dermata Therapeutics Expands At-The-Market Equity Offering Capacity

• TipRanks·01/22 22:05

  Dermata Therapeutics files to sell 1.48M shares of common stock for holders

• TipRanks·01/20 13:55

  Dermata Therapeutics receives notice of grant of patent for acne treatment

• TipRanks·12/29/2025 21:31

  Dermata Therapeutics Raises Capital via December Private Placement

• NASDAQ·12/26/2025 08:28

  Dermata Therapeutics Announces A Private Placement Valued At Up To $12.4 Mln

• TipRanks·12/24/2025 13:15

  Dermata Therapeutics prices 2.02M shares at $2.04 in private placement

• NASDAQ·12/08/2025 15:15

  Dermata Therapeutics To Launch First OTC Acne Kit In Mid-2026